CME in Minutes: Education in Primary Care

Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Primary Care by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives. Inspiring and engaging programs designed for the busy primary care providers to cover the diagnosis, treatment, follow-up, and clinical management of various disease states. Earning your CME/CE credit has never been faster or easier. Visit the URL for each individual program to request continuing education credit or access the slides.

181 episodes

10d ago latest

weekly cadence

English language

▶ Play latestRSS feed Website Science Life Health Fitness Medicine

https://c.answersincme.com/podcast/xml/primary_care.xml

Episodes 183

Bridging Clinical Trial and Real-World Evidence in Retinal Diseases: Updated Strategies With Anti-VEGF Therapies
yesterday · 19:52
Please visit answersincme.com/BWG860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Ferhina Ali, MD, MPH, FASRS. In this activity, an expert in retinal diseases discusses integrating clinical trial and real-world evidence into the use of newer-generation anti–vascular endothelial growth factor (VEGF) agents. Upon completion of this activity, participants should be better able to: Review the role of different types of data in informing management of retinal diseases; Assess clinical trial data and real-world evidence support
Answering Clinician Questions About Anemia in Lower-Risk Myelodysplastic Syndromes: Community-Based Strategies to Enhance Long-Term Efficacy
2d ago · 20:03
Please visit answersincme.com/ZGK860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Amer Zeidan, MBBS, MHS. In this activity, an expert in myelodysplastic syndromes (MDS) discusses approaches to optimize management of anemia in lower-risk MDS. Upon completion of this activity, participants should be better able to: Translate the latest clinical trial data to the management of patients with lower-risk MDS; Evaluate evidence-based strategies for optimizing the use of available agents in lower-risk MDS; and Design treatment pl
Taking Control of Moderate to Severe Bullous Pemphigoid (BP): Expert Insights on Diagnosing BP and Targeting Type 2 Inflammation
9d ago · 14:56
Please visit answersincme.com/ZYD860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by April W. Armstrong, MD, MPH. In this activity, an expert in dermatology discusses best practices to diagnose and manage bullous pemphigoid (BP). Upon completion of this activity, participants should be better able to: Review the process for diagnosing patients with BP; Assess the evidence for the use of biologics targeting type 2 inflammation in the treatment of BP; and Outline the clinical implications of the evidence for the treatment of B
From Initial to Maintenance Pharmacotherapy for EoE: Stepping Up Multidisciplinary Long-Term Care
10d ago · 16:06
Please visit answersincme.com/AQE860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Nirmala Gonsalves, MD, AGAF, FACG. In this activity, an expert in esophageal gastroenterology, discusses strategies for pharmacological treatment of eosinophilic esophagitis (EoE). Upon completion of this activity, participants should be better able to: Specify the current guideline recommendations for the pharmacologic treatment of eosinophilic esophagitis (EoE); Formulate personalized strategies to use approved pharmacologic options during
What’s Next in Anticoagulation? An Evolving Primary Care Playbook for Stroke Prevention in Atrial Fibrillation
11d ago · 1:01:00
Please visit answersincme.com/860/103760795-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Keith C. Ferdinand, MD; Mike Sharma, MD, MSc; and Eddie Needham, MD, FAAFP. In this activity, experts in atrial fibrillation (AF) discuss evidence-based strategies to optimize stroke prevention, address anticoagulation gaps in clinical practice, and prepare for emerging approaches to anticoagulation. Upon completion of this activity, participants should be better able to: Apply evidence-based risk stratification tools and guide
Redefining What’s Possible in mTNBC: The Expanding Frontier of TROP2-Directed ADCs
12d ago · 14:37
Please visit answersincme.com/XUG860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Sara A. Hurvitz, MD, FACP. In this activity, an expert in breast cancer discusses the evidence for TROP2-directed antibody-drug conjugates in metastatic triple-negative disease (mTNBC). Upon completion of this activity, participants should be better able to: Review the clinical impact of TROP2-directed antibody-drug conjugates (ADCs) for the management of mTNBC; Evaluate the clinical implications of the evidence exploring first-line use of T
Conversations in Gene Expression–Based Testing: A Clinician’s Roadmap to Multidisciplinary Melanoma Care
16d ago · 22:20
Please visit answersincme.com/GFY860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Vishal A. Patel, MD; and Jonathan S. Zager, MD, FACS, FSSO. In this activity, experts in cutaneous oncology discuss the evolving role of gene expression profiling (GEP) tests in refining risk assessment and supporting individualized, multidisciplinary management strategies for patients with melanoma. Upon completion of this activity, participants should be better able to: Identify the clinical rationale for using GEP tests to stratify the ri
It’s Not "Just Hives": Advancing Targeted Care in Chronic Spontaneous Urticaria
1mo ago · 1:02:14
Please visit answersincme.com/2026-MC-001884-replay860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Marc Serota, MD; Kristin Sokol, MD, MS, MPH; and Michelle Tarbox, MD. In this activity, experts in chronic spontaneous urticaria (CSU) discuss strategies to reduce diagnostic delays and how to personalize care beyond antihistamines. Upon completion of this activity, participants should be better able to: Recognize the impact of delayed diagnosis on disease control in patients with CSU; Review key inflammatory pathways—inclu
From Evidence to Impact: Leveraging the Latest Data to Elevate Standards and Patient Outcomes in mHSPC
1mo ago · 1:09:28
Please visit answersincme.com/860/101834101-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Simpa S. Salami, MD, MPH; and Neal D. Shore, MD, FACS. In this activity, experts in prostate cancer discuss new evidence for individualized, evidence-based treatment strategies in metastatic hormone-sensitive disease. Upon completion of this activity, participants should be better able to: Evaluate the clinical implications of the most recent data informing the standard of care treatment options for mHSPC; Integrate patient-, d
Management of Overactive Bladder in Patients With Benign Prostatic Hyperplasia: Tailoring Treatment for Individualized Care
1mo ago · 13:04
Please visit answersincme.com/ZPW860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by David R. Staskin, MD. In this activity, an expert in urology discusses strategies to diagnose and individualize treatment for overactive bladder (OAB) in patients with benign prostatic hyperplasia (BPH), including the role of beta-3 adrenergic agonists and guideline-based care. Upon completion of this activity, participants should be better able to: Identify strategies to diagnose overactive bladder (OAB) in patients with benign prostatic hy
Translating Evidence Into Practice: Optimizing Chemotherapy-Free Intervals and Sequencing in mCRC
1mo ago · 15:58
Please visit answersincme.com/TNM860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Richard Kim, MD. In this activity, an expert in oncology discusses when and how to sequence later-line and chemotherapy-free therapies in metastatic colorectal cancer (mCRC). Upon completion of this activity, participants should be better able to: Evaluate factors influencing a treatment switch from cytotoxic agents for patients with stable metastatic colorectal cancer (mCRC); Formulate practical approaches for transitioning from chemotherap
Oncology - Pathology Dialogues: Evolving Diagnostic Pathways to Expand Treatment of Extrapulmonary Neuroendocrine Neoplasms
1mo ago · 26:28
Please visit answersincme.com/KJW860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Aman Chauhan, MD and Rhonda K. Yantiss, MD. In this activity, experts in medical oncology and pathology discuss identification and treatment of extrapulmonary neuroendocrine carcinomas and extrapulmonary neuroendocrine tumors. Upon completion of this activity, participants should be better able to: Differentiate extrapulmonary neuroendocrine carcinoma (EP-NEC) from extrapulmonary neuroendocrine tumors (EP-NETs); Identify diagnostic and patho
Simplify, Personalize, Suppress: Novel Oral ART for HIV Management
1mo ago · 16:01
Please visit answersincme.com/BJN860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Rajesh Gandhi, MD. In this activity, an expert in infectious diseases discusses novel oral antiretroviral therapy (ART) for the management of human immunodeficiency virus (HIV). Upon completion of this activity, participants should be better able to: Recognize the rationale for novel oral ART regimens in the management of virologically suppressed HIV infection; Review the clinical impact of novel emerging oral ART regimens for patients with
Mastering Evolving Standards in Resectable HNSCC: A Case-Based Discussion to Elevate Pre- and Postoperative Care
1mo ago · 18:10
Please visit answersincme.com/DDT860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Robert Haddad, MD. In this activity, an expert in medical oncology discusses locally advanced head and neck squamous cell carcinoma (LA HNSCC). Upon completion of this activity, participants should be better able to: Discuss the clinical implications of the latest data for approved and recommended regimens for resectable LA HNSCC in the pre- and postoperative settings; Outline strategies to integrate immunotherapy into pre- and postoperative
Is Quality Sleep in Menopause Just a Dream? Navigating Hot Flashes, Night Sweats, and Sleep Disturbances With Novel Non-Hormonal Therapies
1mo ago · 1:05:46
Please visit answersincme.com/860/103093269-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Stephanie Faubion, MD, MBA, FACP, MSCP and Shelby Harris, PsyD, CBSM, DBSM. In this activity, experts in menopause discuss diagnosis and management of sleep disturbances due to vasomotor symptoms. Upon completion of this activity, participants should be better able to: Recognize the burden of menopause-related VMS occurring during sleep; Explain the clinical significance of the latest data for novel non-hormonal pharmacotherapi
Closing the Prevention Gap in Adult Pneumococcal Disease: Evolving Evidence for Primary Care and Pharmacy Practice
1mo ago · 17:11
Please visit answersincme.com/RAH860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Alan G. Kaplan, MD, CCFP(EM), FCFP, CPC(HC); Sherilyn Houle, BSP, PhD, CTH, AFTM RCPS(Glasg), FISTM; and Aakash Modi, MD, CFPC, ABFM, FAAFP. In this activity, two experts in adult pneumococcal disease immunization discuss strategies to close the prevention gap in primary care and pharmacy practice. Upon completion of this activity, participants should be better able to: Describe the burden of adult pneumococcal disease in Canada, including t
Practical Conversations on PAH Care: Risk-Based Strategies for Specialists in the Community
1mo ago · 22:24
Please visit answersincme.com/TNH860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Nick H. Kim, MD and Vallerie V. McLaughlin, MD. In this activity, experts in cardiovascular medicine and pulmonology discuss pulmonary arterial hypertension (PAH). Upon completion of this activity, participants should be better able to: Recognize the importance of treatment escalation for appropriate patients with PAH; Design risk-based treatment escalation plans for patients with PAH; Review the clinical impact of guideline-recommended ther
Engaging Adults with SMA: A Discussion on Diagnosis and Long-Term Multidisciplinary Management
1mo ago · 22:34
Please visit answersincme.com/FAJ860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Nancy L. Kuntz, MD; Vanessa Battista, DNP, MBA, CPNP-PC, CHPPN, FPCN, FAAN; and Ethan Hilgert. In this activity, experts in the management of spinal muscular atrophy (SMA) discuss the diagnosis and treatment of late-onset SMA (type 3b, 4) in adults. Upon completion of this activity, participants should be better able to: Recognize clinical features that are suggestive of SMA in adults; Review the evidence for approved disease-modifying thera
Cornerstones of Clinical Care: A Guide for Nurses and NPs on Oral SERDs in Breast Cancer
2mo ago · 16:47
Please visit answersincme.com/GXT860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Sarah Donahue, MPH, ANP, AOCNP. In this activity an expert in breast cancer discusses the efficacy and safety of oral SERDs in HR+, HER2- advanced breast cancer. Upon completion of this activity, participants should be better able to: Review the evidence-based use of oral SERDs in the treatment plan for patients with HR+, HER2- advanced breast cancer; Specify the key roles of nurses and NPs in optimizing the overall care for patients with HR
Beyond Adolescence: Broadening HPV Vaccination Across Diverse Patient Populations
2mo ago · 1:04:40
Please visit answersincme.com/860/240201346-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Shannon Salvador, MD, MSc, FRCSC; Sheila Wijayasinghe, MD, CCFP, MSCP; and Christine Palmay, HBArtSci, MD, CCFP. In this activity, experts in HPV vaccination discuss its critical role in cancer prevention, the latest guideline updates, and strategies to improve uptake in populations of interest. Upon completion of this activity, participants should be better able to: Describe the prevalence and impact of human papilloma virus (
Looking Ahead in Atopic Dermatitis: OX40/OX40L Mechanisms, Multidisciplinary Care, and Meaningful Patient Outcomes
2mo ago · 21:11
Please visit answersincme.com/MRQ860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Alexandra K. Golant, MD; Peter Lio, MD, FAAD; and Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP. In this activity, experts in dermatology discuss the OX40L pathway and its potential role in the treatment of moderate-to-severe atopic dermatitis. Upon completion of this activity, participants should be better able to: Identify the rationale for targeting the OX40/OX40 ligand (OX40L) pathway in the treatment of moderate-to-severe atopic dermatitis
Advancing Rett Care: Translating New Therapeutic Evidence Into Clinical Decision-Making
2mo ago · 11:01
Please visit answersincme.com/UMW860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Jeffrey Neul, MD, PhD. n this activity, an expert in pediatrics and neurology discusses the latest data for treatment of Rett syndrome. Upon completion of this activity, participants should be better able to: Discuss the latest efficacy and safety data for investigational neuroactive pharmacologic therapies in the treatment of RTT; and Translate the latest data into treatment considerations for approved and emerging therapies in RTT.
Beyond the Biomarker: Bridging Patient Voices and Precision Care in HER2-Mutant NSCLC
2mo ago · 19:11
Please visit answersincme.com/CNW860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Stephen V. Liu, MD and Amber Fake. In this activity, an expert in non–small-cell lung cancer (NSCLC) discusses the evolving patient-centered management of HER2-mutant NSCLC, focusing on the use of HER2-targeted TKIs. Upon completion of this activity, participants should be better able to: Describe how HER2-targeted TKIs may address the clinical needs for diverse patient populations with HER2-mutant NSCLC; Implement evidence-based molecular p
The Promise of Oral Therapy for HER2-Mutated NSCLC: Unlocking New Treatment Opportunities With a Familiar Target
2mo ago · 1:13:30
Please visit answersincme.com/860/IME_2025_00012595-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by John V. Heymach, MD, PhD; and Mark Awad, MD, PhD. In this activity, experts in oncology discuss the role of dual and HER2-selective oral tyrosine kinase inhibitors in patients with HER2-mutated non–small-cell lung cancer. Upon completion of this activity, participants should be better able to: Specify how TKIs may address unmet therapeutic needs for diverse patient populations with HER2-mutated NSCLC; Interpret the clin
Managing Type 2 Diabetes Today: Supporting Individualized, Team-Based Care
3mo ago · 1:00:58
Please visit answersincme.com/860/240201372-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Jeffrey Habert, MD, CCFP, FCFP and Maria Anton, RPh, BSc, PharmD. In this activity, experts in type 2 diabetes discuss guideline-recommended goals of treatment and strategies to develop personalized plans that incorporate the latest GLP-1–based therapies. Upon completion of this activity, participants should be better able to: Propose guideline-recommended goals of treatment for adults with T2D; Formulate personalized, evidence

Episodes

Reading the feed…

Also on answersincme.com

More Science shows

Arizona Science

azpm.org

510 episodes · 9d ago

WiTcast

witcastthailand.com

357 episodes · 8d ago

Evrim Ağacı ile Bilime Dair Her Şey!

evrimagaci.org

557 episodes · 8d ago

A Moment of Science

prxu.org

1,000 episodes · 9d ago

Groks Science Radio Show and Podcast

ocf.berkeley.edu

1,000 episodes · 11d ago

Ask the Naked Scientists

thenakedscientists.com

802 episodes · 9d ago

CME in Minutes: Education in Primary Care

Episodes 183

Bridging Clinical Trial and Real-World Evidence in Retinal Diseases: Updated Strategies With Anti-VEGF Therapies

Answering Clinician Questions About Anemia in Lower-Risk Myelodysplastic Syndromes: Community-Based Strategies to Enhance Long-Term Efficacy

Taking Control of Moderate to Severe Bullous Pemphigoid (BP): Expert Insights on Diagnosing BP and Targeting Type 2 Inflammation

From Initial to Maintenance Pharmacotherapy for EoE: Stepping Up Multidisciplinary Long-Term Care

What’s Next in Anticoagulation? An Evolving Primary Care Playbook for Stroke Prevention in Atrial Fibrillation

Redefining What’s Possible in mTNBC: The Expanding Frontier of TROP2-Directed ADCs

Conversations in Gene Expression–Based Testing: A Clinician’s Roadmap to Multidisciplinary Melanoma Care

It’s Not "Just Hives": Advancing Targeted Care in Chronic Spontaneous Urticaria

From Evidence to Impact: Leveraging the Latest Data to Elevate Standards and Patient Outcomes in mHSPC

Management of Overactive Bladder in Patients With Benign Prostatic Hyperplasia: Tailoring Treatment for Individualized Care

Translating Evidence Into Practice: Optimizing Chemotherapy-Free Intervals and Sequencing in mCRC

Oncology - Pathology Dialogues: Evolving Diagnostic Pathways to Expand Treatment of Extrapulmonary Neuroendocrine Neoplasms

Simplify, Personalize, Suppress: Novel Oral ART for HIV Management

Mastering Evolving Standards in Resectable HNSCC: A Case-Based Discussion to Elevate Pre- and Postoperative Care

Is Quality Sleep in Menopause Just a Dream? Navigating Hot Flashes, Night Sweats, and Sleep Disturbances With Novel Non-Hormonal Therapies

Closing the Prevention Gap in Adult Pneumococcal Disease: Evolving Evidence for Primary Care and Pharmacy Practice

Practical Conversations on PAH Care: Risk-Based Strategies for Specialists in the Community

Engaging Adults with SMA: A Discussion on Diagnosis and Long-Term Multidisciplinary Management

Cornerstones of Clinical Care: A Guide for Nurses and NPs on Oral SERDs in Breast Cancer

Beyond Adolescence: Broadening HPV Vaccination Across Diverse Patient Populations

Looking Ahead in Atopic Dermatitis: OX40/OX40L Mechanisms, Multidisciplinary Care, and Meaningful Patient Outcomes

Advancing Rett Care: Translating New Therapeutic Evidence Into Clinical Decision-Making

Beyond the Biomarker: Bridging Patient Voices and Precision Care in HER2-Mutant NSCLC

The Promise of Oral Therapy for HER2-Mutated NSCLC: Unlocking New Treatment Opportunities With a Familiar Target

Managing Type 2 Diabetes Today: Supporting Individualized, Team-Based Care

Episodes

Also on answersincme.com

CME in Minutes: Education in Oncology & Hematology

CME in Minutes: Education in Cardiology & Pulmonology

CME in Minutes: Education in Rheumatology, Immunology, & Infectious Diseases

CME in Minutes: Education in Dermatology

CME in Minutes: Education in Gastroenterology

CME in Minutes: Education in Ophthalmology

More Science shows

Arizona Science

WiTcast

Evrim Ağacı ile Bilime Dair Her Şey!

A Moment of Science

Groks Science Radio Show and Podcast

Ask the Naked Scientists

Episodes 183

Bridging Clinical Trial and Real-World Evidence in Retinal Diseases: Updated Strategies With Anti-VEGF Therapies

Answering Clinician Questions About Anemia in Lower-Risk Myelodysplastic Syndromes: Community-Based Strategies to Enhance Long-Term Efficacy

Taking Control of Moderate to Severe Bullous Pemphigoid (BP): Expert Insights on Diagnosing BP and Targeting Type 2 Inflammation

From Initial to Maintenance Pharmacotherapy for EoE: Stepping Up Multidisciplinary Long-Term Care

What’s Next in Anticoagulation? An Evolving Primary Care Playbook for Stroke Prevention in Atrial Fibrillation

Redefining What’s Possible in mTNBC: The Expanding Frontier of TROP2-Directed ADCs

Conversations in Gene Expression–Based Testing: A Clinician’s Roadmap to Multidisciplinary Melanoma Care

It’s Not "Just Hives": Advancing Targeted Care in Chronic Spontaneous Urticaria

From Evidence to Impact: Leveraging the Latest Data to Elevate Standards and Patient Outcomes in mHSPC

Management of Overactive Bladder in Patients With Benign Prostatic Hyperplasia: Tailoring Treatment for Individualized Care

Translating Evidence Into Practice: Optimizing Chemotherapy-Free Intervals and Sequencing in mCRC

Oncology - Pathology Dialogues: Evolving Diagnostic Pathways to Expand Treatment of Extrapulmonary Neuroendocrine Neoplasms

Simplify, Personalize, Suppress: Novel Oral ART for HIV Management

Mastering Evolving Standards in Resectable HNSCC: A Case-Based Discussion to Elevate Pre- and Postoperative Care

Is Quality Sleep in Menopause Just a Dream? Navigating Hot Flashes, Night Sweats, and Sleep Disturbances With Novel Non-Hormonal Therapies

Closing the Prevention Gap in Adult Pneumococcal Disease: Evolving Evidence for Primary Care and Pharmacy Practice

Practical Conversations on PAH Care: Risk-Based Strategies for Specialists in the Community

Engaging Adults with SMA: A Discussion on Diagnosis and Long-Term Multidisciplinary Management

Cornerstones of Clinical Care: A Guide for Nurses and NPs on Oral SERDs in Breast Cancer

Beyond Adolescence: Broadening HPV Vaccination Across Diverse Patient Populations

Looking Ahead in Atopic Dermatitis: OX40/OX40L Mechanisms, Multidisciplinary Care, and Meaningful Patient Outcomes

Advancing Rett Care: Translating New Therapeutic Evidence Into Clinical Decision-Making

Beyond the Biomarker: Bridging Patient Voices and Precision Care in HER2-Mutant NSCLC

The Promise of Oral Therapy for HER2-Mutated NSCLC: Unlocking New Treatment Opportunities With a Familiar Target

Managing Type 2 Diabetes Today: Supporting Individualized, Team-Based Care